Fused heterocyclic derivative and use thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S236000

Reexamination Certificate

active

08044049

ABSTRACT:
The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof.A compound represented by the formula (I):wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.

REFERENCES:
patent: 7723336 (2010-05-01), Vaccaro et al.
patent: 2010/0216798 (2010-08-01), Nakai et al.
patent: 1 153 920 (2001-11-01), None
patent: 1 415 987 (2004-05-01), None
patent: 8-20584 (1996-01-01), None
patent: 89/01333 (1989-02-01), None
patent: 89/01478 (1989-02-01), None
patent: 98/35958 (1998-08-01), None
patent: 00/42012 (2000-07-01), None
patent: 00/43366 (2000-07-01), None
patent: 01/32651 (2001-05-01), None
patent: 01/60814 (2001-08-01), None
patent: 02/32872 (2002-04-01), None
patent: 2005/066177 (2005-07-01), None
patent: 2007/013673 (2007-02-01), None
patent: 2008/016131 (2007-02-01), None
patent: 2007/025090 (2007-03-01), None
patent: 2007/025540 (2007-03-01), None
patent: 2007/038314 (2007-04-01), None
Barlin, et al., Austral. J. Chem. (1996), 49(4), 443-449 [Barlin (III)].
Stanovnik, et al., Tetrahedron (1967), 23(1), 387-95.
Registry Compound, Oct. 2008.
Bullock, et al., “Structural Basis of Inhibitor Specificity of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM-1) Kinase”, J. Med. Chem. 2005, 48, 7604-7614.
Mourad, et al., “Synthesis of Imidazo[1,2-b]pyridazines: Fenbendazole, Oxifenbendazole Analogs and Related Derivatives”, J. Heterocyclic Chem., 30, 1365-1372, Oct.-Nov. 1993.
Barlin, et al., “Imidazo[1,2-b]pyridazines. II 6-Alkylthio- and 6-Arylthio-3-methoxy- 2-phenylimidazo [1,2-b-]pyridazines” Aust. J. Chem., 1987, 40, 1491-7.
Barlin, et al., “Imidazo[1,2-b]pyridazlines IV Syntheses and Central Nervous System Activities of Some 3-Methoxy-6-phenoxy(substituted phenoxy and naphthylocy)-2-phenylimidazo[1,2-b]pyridazines”, Aust. J. Chem, 1988, 41, 1735-42.
Treb{hacek over (s)}e, et al., “A Direct Conversion of 5,6,7,8-Tetrahydro-2H-1-Benzo-Pyran-2,5-Diones into Substituted 1-Amion-5,6,7,8-Tetra-Hydroquinoline-2,5-Diones”, Heterocycles, vol. 59, No. 1, 129-136, 2003.
Treb{hacek over (s)}e, et al., “Transformation of 5-Oxo Substituted Fused Pyran-2-ones. LactamVersusHydrazone Formation”, Synthetic Communications, 27(15), 2637-2644, 1997.
Goli{hacek over (c)} Grdadolnik, et al., “Structural Investigation of 5-Hydrazono-5,6,7,8-tetrahydro-2H-1-benzopyran-2-ones and 5,6,7,8-Tetrahydroquinoline-2,5(1H)-diones”, J. Chem. Inf. Comput. Sci. 1997, 37, 489-494.
Ishikawa, et al., “Synthesis and Antibacterial Activity of 7 β-[2-(5-Amino-1,2,4-thiadiazol-3-y1)-2(Z)- alkoxyiminoacetamido]-3-[(E)-2-(1-alkylimidazo[1,2-b]pyridazinium-6-yl)thiovinyl]-3-cephem-4-carboxylates and Related Compounds”, The Journal of Antibiotics, 54(3), 257-277, Mar. 2001.
Matter. Alex, “Tumor angiogenesis as a therapeutic target”, DDT vol. 6, No. 19, Oct. 2001, pp. 1005-1024.
Ferrara, et al., “The Biology of Vascular Endothelial Growth Factor”, Endocrine Reviews, vol. 18, No. 1, Feb. 1997, pp. 4-25.
Folkamn, Judah, “Tumor Angiogenesis: Therapeutic Implications, The New England Journal of Medicine”, vol. 285, No. 21, Nov. 1971, pp. 1182-1186.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fused heterocyclic derivative and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused heterocyclic derivative and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocyclic derivative and use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4282406

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.